Inventor
Dirk Scharn
Inventor
Berlin, DE
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
A61KPreparations for medical, dental or toiletry purposes25%
C07DHeterocyclic compounds25%
C07CAcyclic or carbocyclic compounds6%
C07KPeptides6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
PatentTitleYear
8,927,534'Compounds for the inhibition of integrins and use thereof'20158,410,134'8-oxy-quinoline derivatives as bradykinin B2 receptor modulators'20138,309,735'Heterocyclic compounds for the inhibition of integrins and use thereof'20128,071,810'C5a receptor antagonists'20118,029,979'Method for determining the substrate specificity of an enzyme'20117,727,960'C5a receptor antagonists'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2015Based in Berlin, DE· patent location history
2011–2015Patents assigned to HUMMEL GERD (4)· patent assignee history
2011–2015Patents assigned to REINEKE ULRICH (4)· patent assignee history
2011–2015Patents assigned to SCHARN DIRK (4)· patent assignee history
2012–2015Patents assigned to SHIRE ORPHAN THERAPIES GMBH (3)· patent assignee history
2012–2015Patents assigned to CHRISTNER-ALBRECHT CLAUDIA (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HUMMEL GERD | 4 | 2011–2015 |
| REINEKE ULRICH | 4 | 2011–2015 |
| SCHARN DIRKself | 4 | 2011–2015 |
| SHIRE ORPHAN THERAPIES GMBH | 3 | 2012–2015 |
| CHRISTNER-ALBRECHT CLAUDIA | 2 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Berlin, DE | 6 | 2010–2015 |